ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $601,000 | +25.7% | 3,490 | -8.4% | 0.26% | +34.0% |
| Q2 2021 | $478,000 | -26.7% | 3,810 | -20.8% | 0.20% | -28.4% |
| Q1 2021 | $652,000 | +8.8% | 4,810 | +2.8% | 0.28% | +10.4% |
| Q4 2020 | $599,000 | -13.2% | 4,681 | -23.6% | 0.25% | -31.2% |
| Q3 2020 | $690,000 | +29.0% | 6,129 | +9.2% | 0.36% | +43.1% |
| Q2 2020 | $535,000 | -49.0% | 5,613 | -51.9% | 0.25% | -41.3% |
| Q1 2020 | $1,048,000 | +56.2% | 11,664 | -7.8% | 0.43% | +291.8% |
| Q4 2019 | $671,000 | +152.3% | 12,648 | +88.2% | 0.11% | +103.7% |
| Q3 2019 | $266,000 | -8.6% | 6,721 | -5.3% | 0.05% | -11.5% |
| Q2 2019 | $291,000 | +7.4% | 7,095 | +22.1% | 0.06% | -89.4% |
| Q1 2019 | $271,000 | -6.9% | 5,810 | -13.1% | 0.58% | +1054.0% |
| Q4 2018 | $291,000 | -61.2% | 6,685 | -49.0% | 0.05% | -35.9% |
| Q3 2018 | $750,000 | -31.2% | 13,104 | -41.7% | 0.08% | -91.9% |
| Q2 2018 | $1,090,000 | +33.9% | 22,469 | +7.9% | 0.96% | +36.5% |
| Q1 2018 | $814,000 | +96.6% | 20,821 | +113.6% | 0.71% | +35.8% |
| Q4 2017 | $414,000 | +1.0% | 9,748 | -11.2% | 0.52% | +845.5% |
| Q3 2017 | $410,000 | +35.3% | 10,977 | +10.1% | 0.06% | +22.2% |
| Q2 2017 | $303,000 | +17.9% | 9,973 | +2.8% | 0.04% | -2.2% |
| Q1 2017 | $257,000 | +14.7% | 9,701 | +10.6% | 0.05% | -31.3% |
| Q4 2016 | $224,000 | -10.4% | 8,771 | +26.9% | 0.07% | -44.6% |
| Q3 2016 | $250,000 | +6.4% | 6,910 | 0.0% | 0.12% | -30.5% |
| Q2 2016 | $235,000 | +54.6% | 6,910 | +20.0% | 0.17% | -16.7% |
| Q1 2016 | $152,000 | – | 5,756 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |